Clinical trial
Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for…
NCT03347708 · DiscGenics, Inc., Industry · Completed
Key facts
| NCT number | NCT03347708 |
|---|---|
| Title | Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration |
| Official title | A Prospective, Randomized, Double-Blinded, Vehicle- and Placebo-Controlled, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of IDCT in Subjects With Single-Level, Symptomatic Lumbar Intervertebral Disc Degeneration |
| Lead sponsor | DiscGenics, Inc., Industry |
| Collaborators | CTI Clinical Trial and Consulting Services |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Degenerative Disc Disease |
| Intervention type | Biological, Drug |
| Interventions | IDCT, Saline Solution, Sodium Hyaluronate |
| Enrollment | 60 |
| Start date | Feb 26, 2018 |
| Primary completion | Feb 1, 2022 |
| Completion | Nov 10, 2022 |
| First posted | Nov 20, 2017 |
| Last update posted | Jan 25, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: